Role of positron emission tomography with 2-deoxy-2-[ 18 F]fluoro-d-glucose in evaluating the effects of arterial infusion chemotherapy and radiotherapy on pancreatic cancer

Primary and metastatic breast carcinoma: initial clinical evaluation with PET with the radiolabeled glucose analogue 2-[F-18]-fluoro-2-deoxy-D-glucose.

Richard L. Wahl, Robert L. Cody, Gary D. Hutchins et al. · Radiology · 1991 · 433 citations

Medicine, Nuclear Medicine, Radiology +17

Differential diagnosis of lung tumor with positron emission tomography: A prospective study

Kazuo Kubota, T Matsuzawa, T. Fujiwara et al. · Lung Cancer · 1991 · 323 citations

Medicine, Nuclear Medicine, Radiology +17

Noninvasive monitoring of tumor metabolism using fluorodeoxyglucose and positron emission tomography in colorectal cancer liver metastases: correlation with tumor response to fluorouracil.

Michael Findlay, Helen Young, David Cunningham et al. · Journal of Clinical Oncology · 1996 · 312 citations

Medicine, Nuclear Medicine, Oncology +17

Positron emission tomography studies in patients with locally advanced and/or metastatic breast cancer: a method for early therapy evaluation?

T. Jansson, J E Westlin, Håkan Åhlström et al. · Journal of Clinical Oncology · 1995 · 262 citations

Medicine, Nuclear Medicine, Oncology +17

F-18 fluorodeoxyglucose PET in vivo evaluation of pancreatic glucose metabolism for detection of pancreatic cancer.

Roland Bares, P. Klever, S. Hauptmann et al. · Radiology · 1994 · 217 citations

Medicine, Nuclear Medicine, Radiology +17